2731 related articles for article (PubMed ID: 14685679)
21. [Hypertension therapy in practice test. Calcium antagonist receives good marks].
Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
MMW Fortschr Med; 2005 Jan; 147(1-2):51. PubMed ID: 15704573
[No Abstract] [Full Text] [Related]
22. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
23. A rational approach to hypertension treatment in the older patient.
Flack JM; Woolley A; Esunge P; Grimm RH
Geriatrics; 1992 Nov; 47(11):24-8, 33-8. PubMed ID: 1358761
[No Abstract] [Full Text] [Related]
24. Adult hypertension: reducing cardiovascular morbidity and mortality.
Prescrire Int; 2005 Feb; 14(75):25-33. PubMed ID: 15751180
[TBL] [Abstract][Full Text] [Related]
25. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
26. Treating hypertension. Are the right drugs given to the right patients?
Beaulieu MD; Dufresne L; LeBlanc D
Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
Zanchetti A
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
[TBL] [Abstract][Full Text] [Related]
28. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
Schillaci G; Verdecchia P
Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297
[No Abstract] [Full Text] [Related]
29. Managing hypertension using combination therapy.
Frank J
Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
[TBL] [Abstract][Full Text] [Related]
30. Hypertension in the elderly: treatment.
Schulman SP; Gerstenblith G
Cardiol Clin; 1986 May; 4(2):245-52. PubMed ID: 2871936
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of preventive effect of "new" and "old" antihypertensive agents].
Kjeldsen SE; Syvertsen JO; Lund-Johansen P; Hildebrandt P; Hansson L
Tidsskr Nor Laegeforen; 2001 Apr; 121(11):1374-6. PubMed ID: 11419108
[TBL] [Abstract][Full Text] [Related]
32. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
Al Khaja KA; Sequeira RP
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
[TBL] [Abstract][Full Text] [Related]
33. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
34. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
35. [Hypertension 2007-2008].
Chatzikyrkou C; Menne J; Haller H
Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
[TBL] [Abstract][Full Text] [Related]
36. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
Düsing R
Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115
[No Abstract] [Full Text] [Related]
37. Arterial hypertension: second-line treatment. Try other single-agent treatments.
Prescrire Int; 2008 Jun; 17(95):115-8. PubMed ID: 18630388
[TBL] [Abstract][Full Text] [Related]
38. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
39. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
40. Fixed dose combination therapy in the treatment of hypertension.
Stanton T; Reid JL
J Hum Hypertens; 2002 Feb; 16(2):75-8. PubMed ID: 11850763
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]